Long-term Benefit in Chronic Hepatitis B Patients After Standard Peginterferon Alfa Therapy

NCT03181113 · clinicaltrials.gov ↗

COMPLETED

Status

473

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B

Interventions

DRUG: Peginterferon Alfa-2B
DRUG: Peginterferon Alfa-2A

Sponsor

Xiamen Amoytop Biotech Co., Ltd.

Collaborators

[object Object]